44 /100
MEDIUM RISK
Score updated May 30, 2026

XFOR — X4 Pharmaceuticals, Inc. Dilution Risk Tracker

Track XFOR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XFOR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
50
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
📉 Score Deterioration 40%
• Score rose 24 points recently (worsening)
📜 Warrant Exercise 25%
• Significant warrants: 16% of shares outstanding
🔔 Track XFOR — Get forecast alerts →

💹 Market Data

Market Cap$406.52M
Shares Outstanding94.32M
Float57.41M
Cash$233.72M
Debt$77.25M
Short InterestN/A

🏛 Institutional Holdings

77 institutional holders · 86.07M shares
#1 Empery Asset Management, LP 8.95M shares
#2 FMR LLC 8.50M shares
#3 MORGAN STANLEY 8.21M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.92M
Days to Cover8.5
% of Float5.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track XFOR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XFOR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for XFOR
📊 XFOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XFOR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.